Literature DB >> 32306278

Laparoscopic ileo-colic resection and right hemicolectomy for Crohn's disease and colon cancer: a preliminary comparative study on post-operative outcome.

Alessandro Tiberi1, Benedetta Pesi1, Francesco Giudici1, Daniela Zambonin1, Tommaso Nelli2, Curzio Cupellini1, Ferdinando Ficari1, Fabio Cianchi2, Stefano Scaringi3.   

Abstract

Crohn's disease (CD) patients are generally considered at high risk of post-operative complications with respect to non-CD patients. The primary endpoint of this study is to compare early major complications rates between CD and colon cancer (CC) patients undergoing mini-invasive ileo-colic resections or right hemicolectomies. The secondary endpoint is to evaluate the role of pre-operative medication with anti-TNF as a possible risk factor for post-operative complications. An observational retrospective study was carried on patients who underwent mini-invasive ileocolic resections for CD and right hemicolectomies for CC at Digestive Surgery Unit and IBD Unit, Careggi Univeristy Hospital, from January 1, 2008, to June 1, 2019. Data collected included demographic and clinical informations, pre-operative anti-TNF use, major complications and mortality. Hundred and thirty-three mini-invasive ileocolic resections for CD and 131 mini-invasive right hemicolectomies for CC were included. Early major post-operative complications rates were 4.5% for CD patients and 3% for CC patients (p = 0.535). Anastomotic leak rates were 1.5% in both groups. There was no significant difference in mean length of stay; while, mean operation time was significantly longer in CD patients (p < 0.01). Pre-operative use of anti-TNF was not associated with a higher risk for early major post-operative complications in CD patients. In our institution, CD patients undergoing ileocolic resections or right hemicolectomies with a mini-invasive technique do not have a significantly higher risk of postoperative major complications with respect to CC patients, even when treated with anti-TNF agents within 3 months before surgery.

Entities:  

Keywords:  Anti-TNF treatment; Colon cancer; Crohn’s disease; Laparoscopic ileocolic resections; Laparoscopic right hemicolectomies; Post-operative complications

Year:  2020        PMID: 32306278     DOI: 10.1007/s13304-020-00769-8

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  3 in total

1.  Abdominal Surgery in Crohn's Disease: Risk Factors for Complications.

Authors:  Cintia Mayumi Sakurai Kimura; Arceu Scanavini Neto; Natalia Sousa Freitas Queiroz; Natally Horvat; Mariane Gouvea Monteiro Camargo; Marcelo Rodrigues Borba; Carlos Walter Sobrado; Ivan Cecconello; Sergio Carlos Nahas
Journal:  Inflamm Intest Dis       Date:  2020-10-26

2.  Relationship between Nutritional Screening Tools and GLIM in Complicated IBD Requiring Surgery.

Authors:  Camilla Fiorindi; Gabriele Dragoni; Stefano Scaringi; Fabio Staderini; Anita Nannoni; Ferdinando Ficari; Francesco Giudici
Journal:  Nutrients       Date:  2021-10-30       Impact factor: 5.717

3.  Repeated surgery for recurrent Crohn's disease: does the outcome keep worsening operation after operation? A comparative study of 1224 consecutive procedures.

Authors:  Francesco Colombo; Alice Frontali; Caterina Baldi; Maria Cigognini; Giulia Lamperti; Carlo A Manzo; Giovanni Maconi; Sandro Ardizzone; Diego Foschi; Gianluca M Sampietro
Journal:  Updates Surg       Date:  2021-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.